Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes. / Gaede, Peter; Pedersen, Oluf.

In: Annals of Medicine, Vol. 36, No. 5, 2004, p. 355-66.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Gaede, P & Pedersen, O 2004, 'Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes', Annals of Medicine, vol. 36, no. 5, pp. 355-66.

APA

Gaede, P., & Pedersen, O. (2004). Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes. Annals of Medicine, 36(5), 355-66.

Vancouver

Gaede P, Pedersen O. Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes. Annals of Medicine. 2004;36(5):355-66.

Author

Gaede, Peter ; Pedersen, Oluf. / Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes. In: Annals of Medicine. 2004 ; Vol. 36, No. 5. pp. 355-66.

Bibtex

@article{00dd79e8ae1f47daaa24a324525d5279,
title = "Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes",
abstract = "The risk of cardiovascular disease is markedly increased in patients with type 2 diabetes with a prevalence twice as high compared to the background population. With the recognition of multiple concomitant risk factors for both microvascular as well as cardiovascular disease in type 2 diabetic patients, treatment strategies have changed during recent years. This review focuses on the many recent drug trials that have set the course for an effective multifactorial treatment of the disease. Thus, the Steno-2 Study has shown that an intensified multifactorial intervention targeting several risk factors for cardiovascular disease is capable of reducing the risk for a combined endpoint of cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, coronary interventions, revascularisation to legs, and amputations by 50%.",
keywords = "Albuminuria, Angiotensin-Converting Enzyme Inhibitors, Cardiovascular Diseases, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Exercise, Humans, Hyperglycemia, Hyperlipidemias, Hypertension, Risk Factors, Smoking Cessation",
author = "Peter Gaede and Oluf Pedersen",
year = "2004",
language = "English",
volume = "36",
pages = "355--66",
journal = "Medical Biology",
issn = "0785-3890",
publisher = "Taylor & Francis",
number = "5",

}

RIS

TY - JOUR

T1 - Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes

AU - Gaede, Peter

AU - Pedersen, Oluf

PY - 2004

Y1 - 2004

N2 - The risk of cardiovascular disease is markedly increased in patients with type 2 diabetes with a prevalence twice as high compared to the background population. With the recognition of multiple concomitant risk factors for both microvascular as well as cardiovascular disease in type 2 diabetic patients, treatment strategies have changed during recent years. This review focuses on the many recent drug trials that have set the course for an effective multifactorial treatment of the disease. Thus, the Steno-2 Study has shown that an intensified multifactorial intervention targeting several risk factors for cardiovascular disease is capable of reducing the risk for a combined endpoint of cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, coronary interventions, revascularisation to legs, and amputations by 50%.

AB - The risk of cardiovascular disease is markedly increased in patients with type 2 diabetes with a prevalence twice as high compared to the background population. With the recognition of multiple concomitant risk factors for both microvascular as well as cardiovascular disease in type 2 diabetic patients, treatment strategies have changed during recent years. This review focuses on the many recent drug trials that have set the course for an effective multifactorial treatment of the disease. Thus, the Steno-2 Study has shown that an intensified multifactorial intervention targeting several risk factors for cardiovascular disease is capable of reducing the risk for a combined endpoint of cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, coronary interventions, revascularisation to legs, and amputations by 50%.

KW - Albuminuria

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Cardiovascular Diseases

KW - Clinical Trials as Topic

KW - Diabetes Mellitus, Type 2

KW - Exercise

KW - Humans

KW - Hyperglycemia

KW - Hyperlipidemias

KW - Hypertension

KW - Risk Factors

KW - Smoking Cessation

M3 - Journal article

C2 - 15478310

VL - 36

SP - 355

EP - 366

JO - Medical Biology

JF - Medical Biology

SN - 0785-3890

IS - 5

ER -

ID: 38457160